Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine if the Fractionated Laser Resurfacing (FLR) procedure can protect one forearm/wrist from precancerous actinic keratosis (AKs) as well as prevent skin cancer in older subjects with active AKs. This study builds on a similar study ongoing at the Dayton Veterans Administration dermatology clinic. This study is also testing if a photograph of the skin can be used to predict where the AKs and an skin cancers will form.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Fractionated Laser Resurfacing - Right Arm | Experimental | Right forearm treatment of fractionated laser resurfacing. |
|
| Fractionated Laser Resurfacing - Left Arm | Experimental | Left forearm treatment of fractionated laser resurfacing. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Fractionated Laser Resurfacing | Device | A rejuvenating laser that makes tiny holes in the very superficial part of the skin. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline in the number of actinic keratosis due to FLR treatment. | Investigator will assess the number of actinic keratosis on both forearms at each visit. | Up to 5 years |
| Change from baseline in the number of non-melanoma skin cancers due to FLR treatment. | Investigator will assess the number of actinic keratosis on both forearms at each visit. | Up to 5 years |
| Measure | Description | Time Frame |
|---|---|---|
| Skin dysplasia change, in regards to actinic keratosis, from baseline due to FLR treatment. | Investigator will use the scattering patterns of light to assess the number of actinic keratosis on both forearms at each visit. | Up to 5 years |
| Skin dysplasia change, in regards to non-melanoma skin cancer, from baseline due to FLR treatment. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Manager, Clinical Research Operations | Contact | 937-245-7500 | pturesearch@wrightstatephysicians.org | |
| Regulatory Specialist | Contact | 937-245-7500 | pturesearch@wrightstatephysicians.org |
| Name | Affiliation | Role |
|---|---|---|
| Jeffrey Travers, MD, PhD | Wright State University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Wright State Physicians | Recruiting | Fairborn | Ohio | 45324 | United States |
Not provided
| ID | Term |
|---|---|
| D055623 | Keratosis, Actinic |
| ID | Term |
|---|---|
| D011230 | Precancerous Conditions |
| D009369 | Neoplasms |
| D007642 | Keratosis |
| D012871 | Skin Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Investigator will use the scattering patterns of light to assess the number of actinic keratosis on both forearms at each visit. |
| Up to 5 years |
| D017437 |
| Skin and Connective Tissue Diseases |